DFT/NBO analysis of interaction between a CNT and anti-cancer drugs

Document Type : Reasearch Paper

Authors

• N. Dalili Mansour ¹
• F. Mahboubi ²
• N. Nahrjou ¹

¹ Young Researchers and Elite Club, Rasht Branch, Islamic Azad University, Rasht, Iran

² Department of Chemistry, Rasht Branch, Islamic Azad University, Rasht, Iran.

DOI: 10.7508/ijnd.2015.05.005

Abstract

Having conducted fundamental projects, scientists have expressed their hope to develop the use of carbon nanotubes to release drugs. It is important to release drugs in cell without damaging healthy cells of tissues under study. Researchers have shown the fact that nanotubes can perform this function perfectly. To this objective, in the present study the interactions between four anti-cancer drugs with a carbon nanotube (CNT) (6,6), containing 60 carbon atoms, have been investigated. It is noteworthy that all of these drugs have functional groups, from which the reaction with the nanotube can take place. The Density Functional Theory (DFT) calculations have been performed by Beck, three-parameter, Lee-Yang-Parr (B3LYP) method and 6-31G(d) basis set for full optimization of drugs, nanotube and the formed complexes. The Natural Bond Orbital (NBO) analysis and frequency calculations have been also performed for all structures using B3LYP method and 6-31G(d) basis set in 298K. According to the results, among all drugs under study, only two complexes between Carmustine and nanotube can be thermodynamically formed in 298K. The stability constants are calculated thereby showing a considerably large amount. Therefore, the nanotube can be a useful container for this drug. Also, NBO analysis shows that there exist hyperconjugative effects arising from an overlap between occupied orbitals in drugs and unoccupied orbitals in nanotube.

Keywords

• Anti-cancer drug
• Carbon Nanotube
• Drug Delivery
• density functional theory
• Natural bond orbital

20.1001.1.20088868.2015.6.5.5.6

Main Subjects

• Carbon Nanotubs
• Nanochemistry
• Nano Computational
• Nanomedicine

---

References

[1]  Prakash S., Malhotra M., Shao W., Tomaro-Duchesneau C., Abbasi S., (2011), Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy. Adv. Drug Deliv. Rev. 63: 14.15, 1340-1351.

[2]  Li J., Wang Y., Zheng X., Zhang Y., Sun C., Gao Y., Jiang T., Wang S., (2015), The synthesis and application involving regulation of the insoluble drug release from mesoporous silica nanotubes. Appl. Surf. Sci. 330: 374-382.

[3]  Hafizi H., Najafi Chermahini A., Mohammadnezhad G., Teimouri A., (2015), A theoretical study on the interaction of amphetamine and single-walled carbon nanotubes. Appl. Surf. Sci. 329: 87-93.

[4]  Raissi H., Mollania F., (2014), Immunosuppressive agent leflunomide: A SWNTs-immobilized dihydroortate dehydrogenase inhibitory effect and computational study of its adsorption properties on zigzag single-walled (6,0) carbon and boron nitride nanotubes as controlled drug delivery devices. Eur. J. Pharm. Sci. 56: 37-54.

[5]  Shakerzadeh E., Noorizadeh S., (2014), A first principles study of pristine and Al-doped boron nitride nanotubes interacting with platinum-based anticancer drugs. Phys. E. 57: 47-55.

[6]  Karadas N., Ozkan S. A., (2014), Electrochemical preparation of sodium dodecylsulfate doped over-oxidized polypyrrole/multi-walled carbon nanotube composite on glassy carbon electrode and its application on sensitive and selective determination of anticancer drug: Pemetrexed. Talanta. 119: 248-254.

[7]  Wang B. S., Yoong S. L., Jagusiak A., Panczyk T., Ho H. K., Ang W. H., Pastorin G., (2013), Carbon nanotubes for delivery of small molecule drugs. Adv. Drug Deliv. Rev. 65: 1964-2015.

[8]  Huang H., Yuan Q., Shah J. S., Misra R. D. K., (2011), A new family of folate-decorated and carbon nanotubemediated drug delivery system: Synthesis and drug delivery response. Adv. Drug Deliv. Rev. 63: 1332-1339.

[9]  Ewend M. G., Brem S., Gilbert M., Goodkin R., Penar P. L., Varia M., Cush S., Carey L. A., (2007), Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control. Clin. Cancer Res. 13: 3637-3641.

[10] Takimoto C. H., Calvo E., (2005), Principles of oncologic pharmacotherapy. In Pazdur, R., Coia L. R., Hoskins W. J., Wagman L. D. Cancer Management: A Multidisciplinary Approach (9th ed.). 23-42. ISBN 978-1-891483-35-6.

[11] Friedman R., Caflisch A., (2009), Discovery of Plasmepsin Inhibitors by Fragment-Based Docking and Consensus Scoring. Chem. Med. Chem. 4: 1317-1326.

[12] Gamo F. J., Sanz L. M., Vidal J., Cozar C., Alvarez E., Lavandera J. L., Vanderwall D. E., Green D. V. S., Kumar V., Hasan S., Brown J. R., Peishoff C. E., Cardon L. R., Garcia- Bustos J. F., (2010), Thousands of chemical starting points for antimalarial lead identification. Nature. 465: 305-310.

[13] Perdew J. P., Ruzsinszky A., Tao J., Staroverov V. N., Scuseria G., Csonka G. I., (2005), Prescriptions for the design and selection of density functional approximations: More constraint satisfaction with fewer fits. J. Chem. Phys. 123: 062201-0622019.

[14] Becke A. D., (1993). A new mixing of Hartree-Fock and local density-functional theories. J. Chem. Phys. 98: 1372-1377.

[15] Frisch M. J., Trucks G. W., Schlegel H. B., Scuseria G. E., Robb M. A., Cheeseman J. R., Gaussian 03 , Revision C.02 . Gaussian Inc. (2008).

[16] www.jcrystal.com/products/wincnt/.

[17] Frisch A., Nielsen A. B., Holder A. J., Gaussview user Manual , Gaussion Inc (2000).

[18] Http://www.hyper.com/.

[19] Glendening E. D., Reed A. E., Carpenter J. E., Weinhold F., NBO 3.0 Program Manual, http://www.ccl.net/cca/ software/NT/mopac6/nbo.htm.

[20] Levine I. N., (1995), Physical chemistry. McGROWHILL International editions.